Lipid-lowering Therapy Individualization

NCT03604471 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: Atorvastatin

Sponsor

Université Catholique de Louvain

Collaborators

[object Object]